ECGS yields 2000.00% · MRK yields 2.76%● Live data
📍 ECGS pulled ahead of the other in Year 1
Combined, ECGS + MRK cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of ECGS + MRK for your $10,000?
Falcon Technologies, Inc. provides various design-build infrastructure services. The company offers telecommunications and data infrastructure services, which include communications infrastructure services to commercial, government, and other business enterprises. It also provides engineering services, program management, construction, installation and maintenance services, premise wiring services, tower and radio infrastructure services, and technology implementation and integration services, as well as a portfolio of infrastructure engineering and construction services. In addition, it offers design/build, installation, and maintenance services for electrical systems in factories, offices, healthcare facilities, government bases, and installations; and cell-phone relay towers, as well as sells electrical equipment, such as light fixtures, switchgear/panels, and fire alarm and control systems. Further, the company undertakes fire protection contracts in Northern California to provides layout and installation of various types of fire sprinkler systems, including wet and dry pipe, pre-action, in-rack, and fire pump systems in various commercial and industrial applications in new corporate headquarters, shopping centers, multi-tenant buildings, hospitals, nursing facilities, schools, and churches. Additionally, it offers emergency fire protection services with a fleet of approximately 25 service trucks. The company serves commercial builders/developers, government contractors, federal and state governments, education sector, and city/county. Falcon Technologies, Inc. is based in Rancho Cordova, California.
Full ECGS Calculator →Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, such as preventive pediatric, adolescent, and adult vaccines. The Animal Health segment discovers, develops, manufactures, and markets veterinary pharmaceuticals, vaccines, and health management solutions and services, as well as digitally connected identification, traceability, and monitoring products. It serves drug wholesalers and retailers, hospitals, and government agencies; managed health care providers, such as health maintenance organizations, pharmacy benefit managers, and other institutions; and physicians and physician distributors, veterinarians, and animal producers. The company has collaborations with AstraZeneca PLC; Bayer AG; Eisai Co., Ltd.; Ridgeback Biotherapeutics; and Gilead Sciences, Inc. to jointly develop and commercialize long-acting treatments in HIV. Merck & Co., Inc. was founded in 1891 and is headquartered in Kenilworth, New Jersey.
Full MRK Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.